Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox
  2. Müller, Fabian; Cunningham, Tyler; Stookey, Stephanie; Tai, Chin-Hsien; Burkett, Sandra; Jailwala, Parthav; Stetler Stevenson, Maryalice; Cam, Margaret C; Wayne, Alan S; Pastan, Ira
  3. Proceedings of the National Academy of Sciences of the United States of America. 2018, Feb 20; 115(8): E1867-E1875.
  1. 2.   Use of Drosophila deoxynucleoside kinase to study mechanism of toxicity and mutagenicity of deoxycytidine analogs in Escherichia coli
  2. Betham, B.; Shalhout, S.; Marquez, V. E.; Bhagwat, A. S.
  3. DNA Repair. 2010, Feb; 9(2): 153-160.
  1. 3.   2 '-deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: A novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase
  2. Byun, H. M.; Choi, S. H.; Laird, P. W.; Trinh, B.; Siddiqui, M. A.; Marquez, V. E.; Yang, A. S.
  3. Cancer Letters. 2008 266(2): 238-248.
  1. 4.   Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells
  2. Ben-Kasus, T.; Ben-Zvi, Z.; Marquez, V. E.; Kelley, J. A.; Agbaria, R.
  3. Biochemical Pharmacology. 2005, JUL 1; 70(1): 121-133.
  1. 5.   Preferential response of cancer cells to zebularine
  2. Cheng, J. C.; Yoo, C. B.; Weisenberger, D. J.; Chuang, J.; Wozniak, C.; Liang, G. N.; Marquez, V. E.; Greer, S.; Orntoft, T. F.; Thykjaer, T.; Jones, P. A.
  3. Cancer Cell. 2004, AUG; 6(2): 151-158.
  1. 6.   Potent inhibition of HhaI DNA methylase by the aglycon of 2-(1H)-pyrimidinone riboside (Zebularine) at the G(C)under-barGC recognition domain
  2. Marquez, V. E.; Eritja, R.; Kelley, J. A.; Vanbemmel, D.; Christman, J.
  3. THERAPEUTIC OLIGONUCLEOTIDES. 2003; 1002 : 154-164.
  1. 7.   Susceptibility to postnatal growth retardation induced by 5- AZA-2 '-deoxycytidine in utero: Gender specificity and correlation with reduced insulin-like growth factor 1
  2. Cisneros, F. J.; Wilson, R.; Travlos, G.; Anderson, L. M.; Branch, S.
  3. Life Sciences. 2003 72(25): 2887-2894.
  1. 8.   Inhibition of DNA methylation and reactivation of silenced genes by zebularine
  2. Cheng, J. C.; Matsen, C. B.; Gonzales, F. A.; Ye, W.; Greer, S.; Marquez, V. E.; Jones, P. A.; Selker, E. U.
  3. Journal of the National Cancer Institute. 2003 95(5): 399-409.
  1. 9.   Inhibition of HhaI DNA (cytosine-C5) methyltransferase by oligodeoxyribonucleotides containing 5-aza-2 '-deoxycytidine: Examination of the intertwined roles of co-factor, target, transition state structure and enzyme conformation
  2. Brank, A. S.; Eritja, R.; Garcia, R. G.; Marquez, V. E.; Christman, J. K.
  3. Journal of Molecular Biology. 2002 323(1): 53-67.
  1. 10.   Synthesis of oligonucleotide inhibitors of DNA (cytosine-C5) methyltransferase containing 5-azacytosine residues at specific sites
  2. Garcia, R. G.; Brank, A. S.; Christman, J. K.; Marquez, V. E.; Eritja, R.
  3. Antisense and Nucleic Acid Drug Development. 2001 11(6): 369-378.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel